logo
DAHON-V Speed Tech Created Buzz at CHINA CYCLE 2025!

DAHON-V Speed Tech Created Buzz at CHINA CYCLE 2025!

Cision Canada14-05-2025
SHANGHAI, May 14, 2025 /CNW/ -- DAHON, a global leader in the folding bike industry, showcased its vision for the future of cycling at China Cycle 2025, featuring award-winning innovations and the cutting-edge DAHON-V technology. The event attracted large crowds and media attention, highlighting hands-on test rides and competitions that drew crowds and media alike.
DAHON offered an engaging three-part experience, allowing guests to explore the brand's innovation-driven design through tech insights, test rides, and a speed challenge.
Tech Insights
Visitors were introduced to DAHON-V technology via videos, posters, and live demonstrations by staff, providing clear insights into the innovative features from concept to execution.
DAHON-V Speed Challenge
At the heart of the show, DAHON hosted a special DAHON-V Speed Challenge. In it, DAHON's own P8 and Vélodon A4 road bike competed head-to-head with other brands. DAHON bikes stood out with superior acceleration and stability in races, hill climbs and cornering—giving riders and spectators a first-hand experience of the signature DAHON ride.
Full Lineup with DAHON-V: Redefining the Future of Cycling
This year, DAHON unveiled a complete series of revolutionary bikes equipped with DAHON-V, ranging from folding bikes, road bikes, and e-bikes, covering the needs of diverse riders.
Notably, the Télodon C8 AXS carbon fiber folding road bike received a prestigious Gold Award at the 2025 CHINA CYCLE Innovation Awards, among 15 Gold and 55 Excellence Award recipients.
Dr. David T. Hon, Chairman of DAHON Group, stated, "From folding to riding, DAHON has always put user needs on priority one. With our DAHON-V innovation, we're pushing the limits of what a bicycle can be. This exhibition is not just a showcase of our products and technology, but a glimpse into DAHON's vision for the future of urban mobility—where cycling becomes a smarter, greener, and more meaningful lifestyle."
While the event has concluded, DAHON's commitment to innovation continues. In 2025, DAHON will continue driving the industry forward with its DAHON-V technology, expanding globally, and advancing the bicycle industry toward smart, lightweight, and scenario-based innovations.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

More Mexico awaits! WestJet expands codeshare partnership with Aeromexico, unlocking 10 new destinations Français
More Mexico awaits! WestJet expands codeshare partnership with Aeromexico, unlocking 10 new destinations Français

Cision Canada

timean hour ago

  • Cision Canada

More Mexico awaits! WestJet expands codeshare partnership with Aeromexico, unlocking 10 new destinations Français

CALGARY, AB, July 2, 2025 /CNW/ - WestJet today announced an expansion of its reciprocal codeshare partnership with Aeromexico, offering guests on both sides of the continent enhanced access to a broader network of destinations all with the ease of a single booking. Available today, guests travelling to and from WestJet's Canadian network, including its global hub in Calgary, can expand their horizons to some of the airlines' most interesting destinations with the convenience of booking their entire journey on one ticket, seamless single connection, baggage transfers and earning WestJet Rewards throughout. "As the number one Canadian carrier to Mexico, WestJet's expanded partnership with Aeromexico represents a meaningful step forward in deepening the airline's commitment to the region," said John Weatherill, WestJet Executive Vice-President and Chief Commercial Officer. "Our longstanding partnership has always reflected a shared vision to better connect communities across North America. This expansion reinforces our commitment to delivering seamless, accessible travel for our guests, and signals our intent to grow with purpose and partnership for years to come." "As Mexico's Global Airline, our goal is to connect Mexico with the world. To achieve this, partnerships with great allies such as WestJet are essential. We are thrilled about this expansion, through which we will connect WestJet's clients to our domestic network and show the best of Mexico. On the other hand, we will be pleased to offer Aeromexico's travellers more destinations across Canada", said Jose Zapata, Vice-President of Sales for US, Canada and Latin America. Additional codeshare destinations for WestJet guests travelling south From cultural capital cities to hidden gems by the sea, WestJet guests can now enjoy streamlined access to more than 30 destinations across Mexico; ideal for discovering ancient ruins, vibrant culinary scenes or coastal escapes. With codeshare service already available to major Mexican cities such as Guadalajara and Monterrey, guests can also now enjoy expanded connectivity to additional destinations, including: Additional codeshare destinations for Aeromexico guests travelling North The partnership expansion opens options for Mexico-based guests looking to see the best of Canada. Guests travelling from across Aeromexico's network now have access to connect to more than 20 uniquely Canadian destinations from coast-to-coast-to-coast with WestJet including Victoria, Regina, Saskatoon, Ottawa and Halifax. In addition, starting today, guests will have access to three new popular British Columbia destinations including Comox, Cranbrook and Nanaimo as well as the return of codeshare service to St. John's, Newfoundland and Labrador. About WestJet WestJet took to the skies in 1996 with just over 200 employees and three aircraft operating service to five destinations. Since then, WestJet has pioneered low-cost travel in Canada, cutting airfares in half, and increasing the flying population in Canada by more than 50 per cent. Following integration with Sunwing in 2025, more than 14,000 WestJetters support nearly 200 aircraft and connect guests to more than 100 destinations across North America, Central America, the Caribbean, Europe and Asia. As a major Canadian employer that includes WestJet Airlines, Sunwing Vacations Group and WestJet Cargo, the WestJet Group is Canada's leading low-cost airline and largest vacation provider, with a united purpose of providing affordable and accessible air and vacation travel to Canadians. Learn more about WestJet at (also available in French) Follow WestJet on Facebook at Follow WestJet on X at and Follow WestJet on Instagram at Subscribe to WestJet on YouTube at About Grupo Aeromexico Grupo Aeromexico, S.A.B. de C.V., is a holding company with subsidiaries engaged in commercial and cargo aviation in Mexico, training, assistance, and maintenance, as well as the control of its passenger loyalty program: Aeromexico, Aeromexico Connect, Aeromexico Cargo, Aeromexico Formacion, Aeromexico Servicios and Aeromexico Rewards. The company is Mexico's global airline and has its main hub at Mexico City International Airport. Its destinations network features Mexico, the United States, Canada, Central America, South America, Asia, and Europe. The Group's operating fleet is comprised of Boeing 787 and 737 jet airliners and Embraer 190 models. Aeromexico is a founding member of the SkyTeam airline alliance, which celebrated its 25th anniversary and serves 184 countries with its 18 SkyTeam airline partners.

Lotto Max - A $60 million jackpot and an estimated 6 Maxmillions in the next draw Français
Lotto Max - A $60 million jackpot and an estimated 6 Maxmillions in the next draw Français

Cision Canada

timean hour ago

  • Cision Canada

Lotto Max - A $60 million jackpot and an estimated 6 Maxmillions in the next draw Français

MONTRÉAL, July 2, 2025 /CNW/ - In the next Lotto Max draw, slated for Friday, July 4, the prize pool will be $60 million and include a $60 million jackpot and an estimated 6 Maxmillions. "A Lotto Max jackpot was just won in June. We're hoping that Lady Luck strikes again in Québec in Friday's draw, when the jackpot is $60 million," says Isabelle Jean, Executive Vice-President and Chief Operating Officer of Lottery Games at Loto-Québec. Lotto Max continues to churn out winners in Québec Lotto Max players in Québec have won over $3.924 billion since its launch in 2009. In total, there have been 46 jackpot wins in the province, including 3 of $70,000,000—the largest jackpots ever won in Québec—in the February 25 and October 9, 2020, and June 7, 2022, draws. One $65,000,000 jackpot, four $60,000,000 jackpots, five $55,000,000 jackpots, and nine $50,000,000 jackpots have also been won in Quebec. In addition to these jackpot wins, Lotto Max players in Québec have also won a total of 247 Maxmillions prizes, each worth $1 million, and 151 shares of Maxmillions prizes. Draw results are available online at Loto-Québec has been delivering entertainment to Quebecers for over 50 years, and its operations benefit Québec as a whole. Last year, the corporation paid out almost $1.8 billion in prizes to winners across Québec. Major prize winners are listed on the Winners page in the Lotteries section of Read their stories. The responsible commercialization of lottery and gaming products is central to Loto-Québec's operations. The corporation has been granted the highest internationally recognized certification in responsible gaming by the World Lottery Association.

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats
Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats

Cision Canada

timean hour ago

  • Cision Canada

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats

TORONTO, July 2, 2025 /CNW/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept), a biosimilar to Eylea®, indicated for the treatment of neovascular (wet) age-related macular degeneration, macular edema secondary to central or branch retinal vein occlusion, treatment of diabetic macular edema, and treatment of myopic choroidal neovascularization. This approval marks a key milestone for Apotex, introducing its first ophthalmic biosimilar and its fourth biosimilar since 2016, and reflecting the Company's commitment to expand its biologics portfolio and execution of its Journey of Health strategy. "With Aflivu, we're expanding affordable treatment options for Canadians affected by retinal diseases," said Raymond Shelley, President, Apotex Canada. "Apotex continues to deliver innovative, patient-focused solutions across our growing portfolio of brands, biosimilars, generics and consumer health products." "The approval of Aflivu represents a positive advancement in ophthalmic care," said Dr. Bernard R. Hurley, BSc, MD, FRCSC, Assistant Professor at the University of Ottawa Eye Institute. "Biosimilars, supported by clinicians, regulators, and manufacturers, have the potential to transform the treatment landscape for retinal diseases, preserving vision and providing quality, cost-effective care for countless Canadians." "In clinical practice, having access to a broader range of therapeutic options can empower physicians to tailor care to individual patients' needs," said Dr. Ghassan Cordahi, MD, FACS, Assistant Clinical Professor, Faculty of Medicine, Department of Ophthalmology, Université de Montréal. "Aflibercept has been a cornerstone in managing retinal diseases, and the introduction of Aflivu offers a more affordable alternative without compromising quality." Aflivu joins Apotex's successful biosimilar portfolio, which includes Grastofil® (filgrastim), Lapelga® (pegfilgrastim), and Bambevi® (bevacizumab). About Apotex Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people around the world, with a broad portfolio of generic, biosimilar, and innovative branded pharmaceuticals, and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico, and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store